Compare Noble Corporation plc (NE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs State Street SPDR S&P Biotech ETF — how do they compare? Noble Corporation plc trades at $42.53 (market cap $6.48B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Noble Corporation plc pays a 4.93% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Noble Corporation plc nearer its low. Which is the better fit depends on your goals.
| NE | XBI | |
|---|---|---|
Market Cap | $6.48B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $54.37 | $164.28 |
52-Week Low | $25.70 | $85.16 |
Enterprise Value | $7.73B | — |
Dividend Yield | 4.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
